- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩391,000.00
7D
21.2%
1Y
-28.9%
Samsung BiologicsLtd
Market Cap: ₩68.5t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,479,000.00
7D
7.8%
1Y
-12.4%
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩29,150.00
7D
-0.5%
1Y
-7.5%
JW Shinyak
Market Cap: ₩87.6b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,567.00
7D
-25.4%
1Y
1.6%
JW Holdings
Market Cap: ₩248.4b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,590.00
7D
-5.5%
1Y
0.7%
SK Biopharmaceuticals
Market Cap: ₩5.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩75,600.00
7D
-1.6%
1Y
-24.2%